心力衰竭伴快速心房颤动患者采用胺碘酮急诊抢救治疗及对24 h心室率影响分析

doi:10.3969/j.issn.1000-8535.2022.02.006

摘要/Abstract

摘要： 目的分析心力衰竭伴快速心房颤动(简称:心衰伴快速房颤)患者接受胺碘酮急诊抢救治疗的效果及对24 h心室率的影响。方法将2017年1月—2020年12月急诊接诊且行西地兰治疗的60例心衰伴快速房颤患者作为对照组,将同期急诊接诊且行胺碘酮治疗的60例心衰伴快速房颤患者作为观察组,对组间心功能指标、炎症因子水平、心室率、临床疗效、药物不良反应展开分析。结果 ①组间心功能指标、炎症因子水平在治疗前无差异,P>0.05;观察组心功能指标、炎症因子水平在治疗后优于对照组,P<0.05;②组间心室率在治疗前无差异,P>0.05;观察组治疗后4 h、12 h、24 h心室率均低于对照组,P<0.05;③观察组5例无效(8.33%),对照组14例无效(23.33%),P<0.05;④观察组药物不良反应率(3.33%)与对照组药物不良反应率(5.00%)无差异,P>0.05。结论在急诊抢救心衰伴快速房颤患者时采用胺碘酮,可以改善患者心功能、炎症反应、心室率,加之无明显不良反应,值得推广。

关键词: 心力衰竭, 快速心房颤动, 胺碘酮, 急诊, 24 h心室率

Abstract: Objective To analyze the efficacy of emergency treatment with amiodarone and its influence on 24-hour ventricular rate in patients with heart failure and rapid atrial fibrillation. Methods From January 2017 to December 2020, 60 patients with heart failure and rapid atrial fibrillation who received emergency treatment and cedilanide treatment were selected as the control group, and 60 patients with heart failure and rapid atrial fibrillation who received emergency treatment and amiodarone treatment at the same period were selected as the observation group. Results ① There was no significant difference in cardiac function index and inflammatory factors level between the two groups before treatment, P>0.05.The cardiac function index and inflammatory factors level of the observation group were more improved than those of the control group after treatment, P<0.05. ② There was no significant difference in ventricular rate between the two groups before treatment, P>0.05.The ventricular rates of the observation group at 4 h, 12 h and 24 h after treatment were lower than those of the control group, P< 0.05. ③ Treatment for 5 cases (8.33%) in the observation group, 14 cases (23.33%) in the control group were ineffective, P<0.05. ④ There was no significant difference in the adverse drug reaction incidence between the observation group (3.33%) and the control group (5.00%), P>0.05. Conclusion Amiodarone could improve the cardiac function, inflammatory reaction and ventricular rate of patients with heart failure and rapid atrial fibrillation in emergency treatment, and there was no obvious adverse reaction, so it is worthy of promotion.

Key words: heart failure, rapid atrial fibrillation, amiodarone, emergency treatment, 24 h ventricular rate

李建, 王宝玉, 运苛政, 张顺同. 心力衰竭伴快速心房颤动患者采用胺碘酮急诊抢救治疗及对24 h心室率影响分析[J]. 广州医药, 2022, 53(2): 27-30.

LI Jian, WANG Baoyu, YUN Kezheng, ZHANG Shuntong. Emergency treatment with amiodarone in patients with heart failure complicated with rapid atrial fibrillation and its effect on 24-hour ventricular rate[J]. Guangzhou Medical Journal, 2022, 53(2): 27-30.

参考文献

[1] 陈霞.西地兰D与胺碘酮治疗快速型心房纤颤伴急性左心衰的临床效果对比观察及安全性分析[J].中国急救医学,2018,38(z1):22.
[2] 朱小慧,王长远,吉训明,等.NT-proBNP对胺碘酮用于急诊阵发房颤复律疗效的预测价值[J].现代生物医学进展,2019,19(14):2675-2678,2720.
[3] 吴玉国,徐建波,张由建,等.胺碘酮联合美托洛尔治疗老年慢性心力衰竭的临床分析[J].老年医学与保健,2019,25(3):319-322.
[4] 靳彦秋.胺碘酮治疗心力衰竭伴快速房颤的短时疗效探讨[J].世界复合医学,2020,6(10):144-146.
[5] 刘巧兰.胺碘酮对于急性心梗后室性早搏的临床疗效及对心功能的影响[J].心血管康复医学杂志,2020,29(2):219-222.
[6] 刘汉,陈细细.胺碘酮急诊抢救心力衰竭伴快速心房颤动患者的效果观察[J].当代医学,2020,26(29):139-141.
[7] 沈霞.稳心颗粒联合胺碘酮治疗老年心力衰竭合并心房颤动患者的效果[J].中国民康医学,2020,32(18):79-81.
[8] 刘超群,张军.厄贝沙坦联合胺碘酮治疗心力衰竭合并心律失常患者的疗效及对心功能的影响分析[J].中国药物与临床,2020,20(17):2933-2935.
[9] 赵芬芬,杨阳,吴军.胺碘酮治疗急性心力衰竭并快速心律失常的疗效观察[J].吉林医学,2020,41(9):2141-2143.
[10] 孙玮,王彩燕.胺碘酮辅助治疗快速心房颤动合并心力衰竭的效果及对心功能的影响[J].实用临床医药杂志,2020,24(12):63-65.
[11] 潘娜.西地兰在心力衰竭伴快速心房颤动治疗中的疗效[J].中国现代药物应用,2019,13(14):96-97.
[12] 史红革,李莉,黄宇玲,等.胺碘酮联合美托洛尔治疗心力衰竭伴心房颤动疗效的Meta分析[J].现代预防医学,2018,45(24):4521-4525.
[13] 黎德恩,梅啸,李明琰.胸痛中心对ST段抬高型心肌梗死患者救治效果以及1年预后的影响[J].现代医院,2021,21(12):1879-1882,1885.
[14] 吴建辉,张国伟,刘小梅,杨光斌.血清胱抑素C对射血分数降低的慢性心力衰竭患者近期预后的评价价值[J].现代医院,2020,20(2):310-312
[15] 杨晶,邵丽杰,贺显建,等.艾司洛尔与胺碘酮治疗射血分数中间值心力衰竭患者快速房颤的效果观察[J].心脏杂志,2020,32(2):156-159,163.